Panel Discussion and Q&A: Nicotine, Tobacco & Government Policy
Time: 9:50 am - 10:15 am
Date: May 14 2024
may-14-2024 09:50
may-14-2024 10:15
Europe/London
Panel Discussion and Q&A: Nicotine, Tobacco & Government Policy
Has generic language on “tobacco” products undermined understanding and public communication on the “nicotine harm continuum”? How can high-risk adolescents be considered in the drive to reduce youth? Has a more liberal approach to vaping in other countries reduced smoking? Will there be enough PMTA-approved products to meet adult demand? Are the voices of people… Read more »
The E-Cigarette Summit USA- Has generic language on “tobacco” products undermined understanding and public communication on the “nicotine harm continuum”?
- How can high-risk adolescents be considered in the drive to reduce youth?
- Has a more liberal approach to vaping in other countries reduced smoking?
- Will there be enough PMTA-approved products to meet adult demand?
- Are the voices of people who smoke being heard and considered in health equity discussions?
Chair
Prof Robin Mermelstein Distinguished Professor of Psychology and IHRP Director - University of Illinois, Chicago
Session Responder
Alex Clark Chief Executive Officer - CASAA
Speakers
Mitch Zeller J.D Retired Director, Center for Tobacco Products (CTP) - The Food & Drug Administration (FDA)
Deborah Arnott Chief Executive - Action on Smoking and Health (UK)
Ben Youdan Director - ASH New Zealand
Dr Rafael Meza Distinguished Senior Scientist - Integrative Oncology, BC Cancer Research Institute
« Back
